About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The research group in General Surgery aims to develop research activities in the field of Surgery from the most clinical and surgical aspects related to the quality of care to the most basic and translational aspects of etiopathogenesis, pathophysiology and the bases of the diseases included in its different areas of interest, as well as in the therapeutic procedures to address them. It is focused in several topics that include the fields of Abdominal Wall Surgery, biomaterials and bioengineering, Colorectal Surgery and Proctology, General Endocrine, Bariatric and Metabolic Surgery, Esophagogastric Surgery, and Thoracic Surgery. It includes clinical surgeons who make up the care teams of the various clinical lines and includes a basic research laboratory with two researchers with special interest in the study of the extracellular matrix and inflammation and biomaterials and their integration.
The donation will support a research line focused on understanding the progression of this inflammatory liver disease and improving treatment personalisation.
The document provides a comprehensive evaluation of current knowledge on this type of cancer affecting the bile ducts.
Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research
